TerminatedPhase 2NCT05122182
Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19
Studying Severe acute respiratory syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Sydney
- Principal Investigator
- Meg JardineNHMRC Clinical Trials Centre, The University of Sydney
- Intervention
- Candesartan Cilexetil(drug)
- Enrollment
- 49 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2023
Study locations (10)
- Jawaharlal Nehru Medical College and Hospital, Aligarh, India
- Government Medical College and Hospital, Chandigarh, India
- Samishta Hospital and Research Institute, Guntur, India
- Maharaja Agrasen Hospital, Jaipur, India
- Amrita Institute of Medical Science, Kochi, India
- Kasturba Medical College, Mangaluru, India
- DM Wayanad Institute of Medical Sciences, Meppādi, India
- Sterling Hospital, Nigdi, India
- Jivanrekha Multi-Speciality Hospital, Pune, India
- All India Institute of Medical Sciences, Raipur, Raipur, India
Collaborators
The George Institute
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05122182 on ClinicalTrials.govOther trials for Severe acute respiratory syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06099795Evaluation of Concordance Between Exhaled Air Test (eBAM-CoV) and RT-PCR to Detect SARS-CoV-2Centre Hospitalier Universitaire de Nīmes
- RECRUITINGPHASE4NCT06585241A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine FormulationsModernaTX, Inc.
- RECRUITINGNCT06168019Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in IndiaBoston University
- RECRUITINGEARLY PHASE1NCT05656105Positron Emission Tomography (PET) Imaging of Neuroinflammation in Patients With Neurological Dysfunction After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS CoV 2) InfectionUniversity of Alabama at Birmingham
- RECRUITINGNCT05892549COVID-19: Early Detection of Worsening by Voice and Respiratory Pattern CharacteristicsDirection Centrale du Service de Santé des Armées
- RECRUITINGNANCT05566483Physiology of Long COVID-19 and the Impact of Cardiopulmonary Rehabilitation on Quality-of-Life and Functional CapacityUniversity of Colorado, Denver
- ACTIVE NOT RECRUITINGNCT05787964Immunity to Infection in Healthy Participants and Participants With CancerUniversity Hospital Tuebingen
- RECRUITINGPHASE2, PHASE3NCT05543616A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy ChildrenBioNTech SE